CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early after only 17 patients
Disease control TerminatedThis early-stage study tested a new drug called BDC-3042, alone or with another drug (cemiplimab), in 17 people with advanced cancers such as breast, kidney, ovarian, head and neck, colorectal, lung, and skin cancer. The main goal was to check safety and find the right dose. The …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 01:04 UTC
-
Cancer combo trial halted early: what we know
Disease control TerminatedThis study tested a combination of two drugs, niraparib and dostarlimab, in adults with advanced solid tumors that had DNA repair problems or were sensitive to platinum chemotherapy. The goal was to see how many patients' tumors shrank or disappeared. The trial was stopped early …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested two new drug combinations for people with advanced clear cell kidney cancer that had already been treated. The goal was to see if adding the experimental drug NKT2152 to standard therapies could shrink tumors or slow the disease. The trial was stopped early, so …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New pill shows promise in halting advanced kidney cancer growth
Disease control TerminatedThis trial tested an oral drug called NKT2152 for people with advanced clear cell kidney cancer that has worsened after other treatments. The drug works by blocking a protein that helps cancer grow. The study aimed to find the safest dose and see if it can shrink tumors or slow t…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Immunotherapy before kidney surgery shows promise in small trial
Disease control TerminatedThis study tested giving pembrolizumab (with or without axitinib) before surgery to people with advanced kidney cancer that had spread. The goal was to see if this approach could boost the immune system's attack on the tumor and help control the cancer better than surgery alone. …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC